Obesity reshapes host defenses through metabolic and inflammatory pathways that alter how the body recognizes, contains, and clears infections. Research by Gokhan S. Hotamisligil Harvard T.H. Chan School of Public Health has shown that enlarged adipose tissue becomes a source of persistent immune signaling, producing proinflammatory cytokines such as tumor necrosis factor alpha and interleukin 6 and disrupting insulin and lipid metabolism. Those changes create a state of chronic low-grade inflammation that modifies baseline immune activity and raises the threshold for effective responses to pathogens.
Mechanisms linking adiposity to immune dysfunction
Adipose tissue in obesity increases secretion of adipokines and recruits proinflammatory macrophages, shifting macrophage polarization toward an M1 phenotype and sustaining local and systemic inflammation. Vishwa D. Dixit Yale School of Medicine has described how metabolic stress in obesity activates the NLRP3 inflammasome and accelerates immune cell aging, impairing innate pattern recognition and decreasing the coordination of early responses. At the cellular level, T lymphocytes show altered metabolism and reduced proliferative capacity, while B cell function and antibody quality can be diminished, producing weaker adaptive immunity. Metabolic signaling pathways such as leptin signaling also modulate T cell differentiation, so hormonal resistance in obesity further skews immune outcomes.
Clinical and societal consequences
Clinically, this biology translates into higher risk of severe disease for respiratory infections and other pathogens and reduced effectiveness of vaccines in some contexts. The Centers for Disease Control and Prevention classifies obesity as a risk factor for more severe outcomes from influenza and SARS-CoV-2 infection and notes prolonged viral shedding and greater hospitalization risk among people with obesity. Consequences extend beyond individual health: communities with higher obesity prevalence, often shaped by socioeconomic and environmental factors such as limited access to healthy foods and safe exercise spaces, face disproportionate burdens during epidemics and increased strain on health systems.
Understanding these links informs prevention and treatment strategies that combine metabolic control with infection management. Addressing obesity through policy, community-level interventions, and clinical care can reduce the inflammatory milieu that undermines immune competence and improve resilience to infectious disease across populations.